Request for Covid-19 Impact Assessment of this Report
The United States Mebeverine market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mebeverine market, reaching US$ million by the year 2028. As for the Europe Mebeverine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Mebeverine players cover Abbott, Mylan, Greville Investing Limited, and Expanscience, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Mebeverine market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Capsule
Tablet
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug Store
On-line
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott
Mylan
Greville Investing Limited
Expanscience
Berlin Pharmaceutical
Eipico Pharmaceutical
Sopharma
USV Private Limited
Puren Pharma
Pharco
Swiss Pharm
Dr. Reddy's
Aurovitas Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mebeverine Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Mebeverine by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Mebeverine by Country/Region, 2017, 2022 & 2028
2.2 Mebeverine Segment by Type
2.2.1 Capsule
2.2.2 Tablet
2.3 Mebeverine Sales by Type
2.3.1 Global Mebeverine Sales Market Share by Type (2017-2022)
2.3.2 Global Mebeverine Revenue and Market Share by Type (2017-2022)
2.3.3 Global Mebeverine Sale Price by Type (2017-2022)
2.4 Mebeverine Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 On-line
2.5 Mebeverine Sales by Application
2.5.1 Global Mebeverine Sale Market Share by Application (2017-2022)
2.5.2 Global Mebeverine Revenue and Market Share by Application (2017-2022)
2.5.3 Global Mebeverine Sale Price by Application (2017-2022)
3 Global Mebeverine by Company
3.1 Global Mebeverine Breakdown Data by Company
3.1.1 Global Mebeverine Annual Sales by Company (2020-2022)
3.1.2 Global Mebeverine Sales Market Share by Company (2020-2022)
3.2 Global Mebeverine Annual Revenue by Company (2020-2022)
3.2.1 Global Mebeverine Revenue by Company (2020-2022)
3.2.2 Global Mebeverine Revenue Market Share by Company (2020-2022)
3.3 Global Mebeverine Sale Price by Company
3.4 Key Manufacturers Mebeverine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mebeverine Product Location Distribution
3.4.2 Players Mebeverine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Mebeverine by Geographic Region
4.1 World Historic Mebeverine Market Size by Geographic Region (2017-2022)
4.1.1 Global Mebeverine Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Mebeverine Annual Revenue by Geographic Region
4.2 World Historic Mebeverine Market Size by Country/Region (2017-2022)
4.2.1 Global Mebeverine Annual Sales by Country/Region (2017-2022)
4.2.2 Global Mebeverine Annual Revenue by Country/Region
4.3 Americas Mebeverine Sales Growth
4.4 APAC Mebeverine Sales Growth
4.5 Europe Mebeverine Sales Growth
4.6 Middle East & Africa Mebeverine Sales Growth
5 Americas
5.1 Americas Mebeverine Sales by Country
5.1.1 Americas Mebeverine Sales by Country (2017-2022)
5.1.2 Americas Mebeverine Revenue by Country (2017-2022)
5.2 Americas Mebeverine Sales by Type
5.3 Americas Mebeverine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mebeverine Sales by Region
6.1.1 APAC Mebeverine Sales by Region (2017-2022)
6.1.2 APAC Mebeverine Revenue by Region (2017-2022)
6.2 APAC Mebeverine Sales by Type
6.3 APAC Mebeverine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Mebeverine by Country
7.1.1 Europe Mebeverine Sales by Country (2017-2022)
7.1.2 Europe Mebeverine Revenue by Country (2017-2022)
7.2 Europe Mebeverine Sales by Type
7.3 Europe Mebeverine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mebeverine by Country
8.1.1 Middle East & Africa Mebeverine Sales by Country (2017-2022)
8.1.2 Middle East & Africa Mebeverine Revenue by Country (2017-2022)
8.2 Middle East & Africa Mebeverine Sales by Type
8.3 Middle East & Africa Mebeverine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Mebeverine
10.3 Manufacturing Process Analysis of Mebeverine
10.4 Industry Chain Structure of Mebeverine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Mebeverine Distributors
11.3 Mebeverine Customer
12 World Forecast Review for Mebeverine by Geographic Region
12.1 Global Mebeverine Market Size Forecast by Region
12.1.1 Global Mebeverine Forecast by Region (2023-2028)
12.1.2 Global Mebeverine Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Mebeverine Forecast by Type
12.7 Global Mebeverine Forecast by Application
13 Key Players Analysis
13.1 Abbott
13.1.1 Abbott Company Information
13.1.2 Abbott Mebeverine Product Offered
13.1.3 Abbott Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Abbott Main Business Overview
13.1.5 Abbott Latest Developments
13.2 Mylan
13.2.1 Mylan Company Information
13.2.2 Mylan Mebeverine Product Offered
13.2.3 Mylan Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan Main Business Overview
13.2.5 Mylan Latest Developments
13.3 Greville Investing Limited
13.3.1 Greville Investing Limited Company Information
13.3.2 Greville Investing Limited Mebeverine Product Offered
13.3.3 Greville Investing Limited Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Greville Investing Limited Main Business Overview
13.3.5 Greville Investing Limited Latest Developments
13.4 Expanscience
13.4.1 Expanscience Company Information
13.4.2 Expanscience Mebeverine Product Offered
13.4.3 Expanscience Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Expanscience Main Business Overview
13.4.5 Expanscience Latest Developments
13.5 Berlin Pharmaceutical
13.5.1 Berlin Pharmaceutical Company Information
13.5.2 Berlin Pharmaceutical Mebeverine Product Offered
13.5.3 Berlin Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Berlin Pharmaceutical Main Business Overview
13.5.5 Berlin Pharmaceutical Latest Developments
13.6 Eipico Pharmaceutical
13.6.1 Eipico Pharmaceutical Company Information
13.6.2 Eipico Pharmaceutical Mebeverine Product Offered
13.6.3 Eipico Pharmaceutical Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Eipico Pharmaceutical Main Business Overview
13.6.5 Eipico Pharmaceutical Latest Developments
13.7 Sopharma
13.7.1 Sopharma Company Information
13.7.2 Sopharma Mebeverine Product Offered
13.7.3 Sopharma Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sopharma Main Business Overview
13.7.5 Sopharma Latest Developments
13.8 USV Private Limited
13.8.1 USV Private Limited Company Information
13.8.2 USV Private Limited Mebeverine Product Offered
13.8.3 USV Private Limited Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 USV Private Limited Main Business Overview
13.8.5 USV Private Limited Latest Developments
13.9 Puren Pharma
13.9.1 Puren Pharma Company Information
13.9.2 Puren Pharma Mebeverine Product Offered
13.9.3 Puren Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Puren Pharma Main Business Overview
13.9.5 Puren Pharma Latest Developments
13.10 Pharco
13.10.1 Pharco Company Information
13.10.2 Pharco Mebeverine Product Offered
13.10.3 Pharco Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Pharco Main Business Overview
13.10.5 Pharco Latest Developments
13.11 Swiss Pharm
13.11.1 Swiss Pharm Company Information
13.11.2 Swiss Pharm Mebeverine Product Offered
13.11.3 Swiss Pharm Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Swiss Pharm Main Business Overview
13.11.5 Swiss Pharm Latest Developments
13.12 Dr. Reddy's
13.12.1 Dr. Reddy's Company Information
13.12.2 Dr. Reddy's Mebeverine Product Offered
13.12.3 Dr. Reddy's Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Dr. Reddy's Main Business Overview
13.12.5 Dr. Reddy's Latest Developments
13.13 Aurovitas Pharma
13.13.1 Aurovitas Pharma Company Information
13.13.2 Aurovitas Pharma Mebeverine Product Offered
13.13.3 Aurovitas Pharma Mebeverine Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Aurovitas Pharma Main Business Overview
13.13.5 Aurovitas Pharma Latest Developments
14 Research Findings and Conclusion
Table 1. Mebeverine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Mebeverine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Capsule
Table 4. Major Players of Tablet
Table 5. Global Mebeverine Sales by Type (2017-2022) & (K Units)
Table 6. Global Mebeverine Sales Market Share by Type (2017-2022)
Table 7. Global Mebeverine Revenue by Type (2017-2022) & ($ million)
Table 8. Global Mebeverine Revenue Market Share by Type (2017-2022)
Table 9. Global Mebeverine Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Mebeverine Sales by Application (2017-2022) & (K Units)
Table 11. Global Mebeverine Sales Market Share by Application (2017-2022)
Table 12. Global Mebeverine Revenue by Application (2017-2022)
Table 13. Global Mebeverine Revenue Market Share by Application (2017-2022)
Table 14. Global Mebeverine Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Mebeverine Sales by Company (2020-2022) & (K Units)
Table 16. Global Mebeverine Sales Market Share by Company (2020-2022)
Table 17. Global Mebeverine Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Mebeverine Revenue Market Share by Company (2020-2022)
Table 19. Global Mebeverine Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Mebeverine Producing Area Distribution and Sales Area
Table 21. Players Mebeverine Products Offered
Table 22. Mebeverine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Mebeverine Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Mebeverine Sales Market Share Geographic Region (2017-2022)
Table 27. Global Mebeverine Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Mebeverine Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Mebeverine Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Mebeverine Sales Market Share by Country/Region (2017-2022)
Table 31. Global Mebeverine Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Mebeverine Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Mebeverine Sales by Country (2017-2022) & (K Units)
Table 34. Americas Mebeverine Sales Market Share by Country (2017-2022)
Table 35. Americas Mebeverine Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Mebeverine Revenue Market Share by Country (2017-2022)
Table 37. Americas Mebeverine Sales by Type (2017-2022) & (K Units)
Table 38. Americas Mebeverine Sales Market Share by Type (2017-2022)
Table 39. Americas Mebeverine Sales by Application (2017-2022) & (K Units)
Table 40. Americas Mebeverine Sales Market Share by Application (2017-2022)
Table 41. APAC Mebeverine Sales by Region (2017-2022) & (K Units)
Table 42. APAC Mebeverine Sales Market Share by Region (2017-2022)
Table 43. APAC Mebeverine Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Mebeverine Revenue Market Share by Region (2017-2022)
Table 45. APAC Mebeverine Sales by Type (2017-2022) & (K Units)
Table 46. APAC Mebeverine Sales Market Share by Type (2017-2022)
Table 47. APAC Mebeverine Sales by Application (2017-2022) & (K Units)
Table 48. APAC Mebeverine Sales Market Share by Application (2017-2022)
Table 49. Europe Mebeverine Sales by Country (2017-2022) & (K Units)
Table 50. Europe Mebeverine Sales Market Share by Country (2017-2022)
Table 51. Europe Mebeverine Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Mebeverine Revenue Market Share by Country (2017-2022)
Table 53. Europe Mebeverine Sales by Type (2017-2022) & (K Units)
Table 54. Europe Mebeverine Sales Market Share by Type (2017-2022)
Table 55. Europe Mebeverine Sales by Application (2017-2022) & (K Units)
Table 56. Europe Mebeverine Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Mebeverine Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Mebeverine Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Mebeverine Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Mebeverine Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Mebeverine Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Mebeverine Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Mebeverine Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Mebeverine Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Mebeverine
Table 66. Key Market Challenges & Risks of Mebeverine
Table 67. Key Industry Trends of Mebeverine
Table 68. Mebeverine Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Mebeverine Distributors List
Table 71. Mebeverine Customer List
Table 72. Global Mebeverine Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Mebeverine Sales Market Forecast by Region
Table 74. Global Mebeverine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Mebeverine Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Mebeverine Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Mebeverine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Mebeverine Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Mebeverine Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Mebeverine Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Mebeverine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Mebeverine Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Mebeverine Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Mebeverine Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Mebeverine Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Mebeverine Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Mebeverine Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Mebeverine Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Mebeverine Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Mebeverine Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Mebeverine Revenue Market Share Forecast by Application (2023-2028)
Table 92. Abbott Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 93. Abbott Mebeverine Product Offered
Table 94. Abbott Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Abbott Main Business
Table 96. Abbott Latest Developments
Table 97. Mylan Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan Mebeverine Product Offered
Table 99. Mylan Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Mylan Main Business
Table 101. Mylan Latest Developments
Table 102. Greville Investing Limited Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 103. Greville Investing Limited Mebeverine Product Offered
Table 104. Greville Investing Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Greville Investing Limited Main Business
Table 106. Greville Investing Limited Latest Developments
Table 107. Expanscience Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 108. Expanscience Mebeverine Product Offered
Table 109. Expanscience Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Expanscience Main Business
Table 111. Expanscience Latest Developments
Table 112. Berlin Pharmaceutical Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 113. Berlin Pharmaceutical Mebeverine Product Offered
Table 114. Berlin Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Berlin Pharmaceutical Main Business
Table 116. Berlin Pharmaceutical Latest Developments
Table 117. Eipico Pharmaceutical Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 118. Eipico Pharmaceutical Mebeverine Product Offered
Table 119. Eipico Pharmaceutical Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Eipico Pharmaceutical Main Business
Table 121. Eipico Pharmaceutical Latest Developments
Table 122. Sopharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 123. Sopharma Mebeverine Product Offered
Table 124. Sopharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Sopharma Main Business
Table 126. Sopharma Latest Developments
Table 127. USV Private Limited Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 128. USV Private Limited Mebeverine Product Offered
Table 129. USV Private Limited Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. USV Private Limited Main Business
Table 131. USV Private Limited Latest Developments
Table 132. Puren Pharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 133. Puren Pharma Mebeverine Product Offered
Table 134. Puren Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Puren Pharma Main Business
Table 136. Puren Pharma Latest Developments
Table 137. Pharco Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 138. Pharco Mebeverine Product Offered
Table 139. Pharco Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Pharco Main Business
Table 141. Pharco Latest Developments
Table 142. Swiss Pharm Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 143. Swiss Pharm Mebeverine Product Offered
Table 144. Swiss Pharm Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Swiss Pharm Main Business
Table 146. Swiss Pharm Latest Developments
Table 147. Dr. Reddy's Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 148. Dr. Reddy's Mebeverine Product Offered
Table 149. Dr. Reddy's Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Dr. Reddy's Main Business
Table 151. Dr. Reddy's Latest Developments
Table 152. Aurovitas Pharma Basic Information, Mebeverine Manufacturing Base, Sales Area and Its Competitors
Table 153. Aurovitas Pharma Mebeverine Product Offered
Table 154. Aurovitas Pharma Mebeverine Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Aurovitas Pharma Main Business
Table 156. Aurovitas Pharma Latest Developments
List of Figures
Figure 1. Picture of Mebeverine
Figure 2. Mebeverine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mebeverine Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Mebeverine Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Mebeverine Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Capsule
Figure 10. Product Picture of Tablet
Figure 11. Global Mebeverine Sales Market Share by Type in 2021
Figure 12. Global Mebeverine Revenue Market Share by Type (2017-2022)
Figure 13. Mebeverine Consumed in Hospital
Figure 14. Global Mebeverine Market: Hospital (2017-2022) & (K Units)
Figure 15. Mebeverine Consumed in Drug Store
Figure 16. Global Mebeverine Market: Drug Store (2017-2022) & (K Units)
Figure 17. Mebeverine Consumed in On-line
Figure 18. Global Mebeverine Market: On-line (2017-2022) & (K Units)
Figure 19. Global Mebeverine Sales Market Share by Application (2017-2022)
Figure 20. Global Mebeverine Revenue Market Share by Application in 2021
Figure 21. Mebeverine Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Mebeverine Revenue Market Share by Company in 2021
Figure 23. Global Mebeverine Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Mebeverine Revenue Market Share by Geographic Region in 2021
Figure 25. Global Mebeverine Sales Market Share by Region (2017-2022)
Figure 26. Global Mebeverine Revenue Market Share by Country/Region in 2021
Figure 27. Americas Mebeverine Sales 2017-2022 (K Units)
Figure 28. Americas Mebeverine Revenue 2017-2022 ($ Millions)
Figure 29. APAC Mebeverine Sales 2017-2022 (K Units)
Figure 30. APAC Mebeverine Revenue 2017-2022 ($ Millions)
Figure 31. Europe Mebeverine Sales 2017-2022 (K Units)
Figure 32. Europe Mebeverine Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Mebeverine Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Mebeverine Revenue 2017-2022 ($ Millions)
Figure 35. Americas Mebeverine Sales Market Share by Country in 2021
Figure 36. Americas Mebeverine Revenue Market Share by Country in 2021
Figure 37. United States Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Mebeverine Sales Market Share by Region in 2021
Figure 42. APAC Mebeverine Revenue Market Share by Regions in 2021
Figure 43. China Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Mebeverine Sales Market Share by Country in 2021
Figure 50. Europe Mebeverine Revenue Market Share by Country in 2021
Figure 51. Germany Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Mebeverine Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Mebeverine Revenue Market Share by Country in 2021
Figure 58. Egypt Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Mebeverine Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Mebeverine in 2021
Figure 64. Manufacturing Process Analysis of Mebeverine
Figure 65. Industry Chain Structure of Mebeverine
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...